Razavi International Journal of Medicine

Published by: Kowsar

Evaluation of the Relationship Between Prostate-Specific Antigen and Prostate Size and Also PSA and BMI in Subjects Referred to the Check-up Clinic of Razavi Hospital

Ali Abdolhosseini 1 , * , Kambiz Totonchi Sarraf 1 , Azra Izanloo 1 and Najme Jafari 1
Authors Information
1 Department of Education and Research, Razavi Hospital, Mashhad, IR Iran
Article information
  • Razavi International Journal of Medicine: June 3, 2014, 2 (2); e15534
  • Published Online: June 3, 2014
  • Article Type: Discussion
  • Received: October 21, 2013
  • Revised: December 22, 2013
  • Accepted: March 12, 2014
  • DOI: 10.5812/rijm.15534

To Cite: Abdolhosseini A, Totonchi Sarraf K, Izanloo A, Jafari N. Evaluation of the Relationship Between Prostate-Specific Antigen and Prostate Size and Also PSA and BMI in Subjects Referred to the Check-up Clinic of Razavi Hospital, Razavi Int J Med. 2014 ; 2(2):e15534. doi: 10.5812/rijm.15534.

Abstract
Copyright © 2014, Razavi Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Carter HB, partin AW. Campbell-Walsh Urology. 2002;
  • 2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1): 10-30[PubMed]
  • 3. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990; 17(4): 337-47[PubMed]
  • 4. Glovamucci EP. prostate cancer principles and practice. 2002;
  • 5. Stephan C, Xu C, Cammann H, Graefen M, Haese A, Huland H, et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol. 2007; 25(1): 95-103[DOI][PubMed]
  • 6. Olsen SH, Walzak J. Prostate cancer: rate and risk. Atlantic cancer genetics network. 2002; 68(4): 36-8
  • 7. Tulloch-Reid MK, Aiken WD, Morrison BF, Tulloch T, Mayhew R, Wan RL, et al. Body mass index and prostate specific antigen levels in Jamaican men. West Indian Med J. 2011; 60(3): 316-21[PubMed]
  • 8. Cox AK, Holliday RE, Gregory PS, Joseph WA, Fei D. The effects of body mass index on pretreatment characteristics, treatment choice, and response to treatment of intermediate- and high-grade prostate cancer. J Clin Oncol. 2012; 30(5)
  • 9. Lujan M, Paez A, Llanes L, Miravalles E, Berenguer A. Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer? Prostate Cancer Prostatic Dis. 2001; 4(3): 146-9[DOI][PubMed]
  • 10. Ayatollahi SM, Khezri AA, Shirazi M, Lotfi M, Askarian M, Ariafar A, et al. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Iran J Immunol. 2009; 6(1): 40-8[PubMed]
  • 11. Pater LE, Hart KW, Blonigen BJ, Lindsell CJ, Barrett WL. Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population. Am J Clin Oncol. 2012; 35(5): 490-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments